Form 4: Chemed Corp CEO Sells 2,000 Shares of Capital Stock

Chemed Corp's CEO, Kevin J. McNamara, sold 2,000 shares of capital stock at a weighted average price of $572.77 on November 25, 2024.

Summary

• Kevin J. McNamara, the President and CEO of Chemed Corp, sold 2,000 shares of the company's capital stock on November 25, 2024.
• The shares were sold at a weighted average price of $572.77 per share.
• The sale was executed in multiple transactions with prices ranging from $571.93 to $573.89.
• Following the transaction, McNamara directly owns 101,735 shares of Chemed Corp's capital stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by an executive, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
• Similar transactions are regularly reported by executives of comparable companies in the healthcare sector, such as HCA Healthcare and Universal Health Services.

Stakeholder Impact

• The stock sale by the CEO may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's overall performance.

Key Dates

Keywords

Chemed Corp, Kevin J. McNamara, stock sale, insider trading, capital stock, SEC Form 4